Highest-materiality recent filing
AI Financial receives Nasdaq delisting notice for bid price below $1.00
Notified July 1, 2026 of non-compliance with Nasdaq minimum $1.00 bid price rule.
AiFi says $180M WLFI tokens available; resolves going concern doubt
Holds ~6.9B WLFI tokens valued at ~$380M at $0.055/token as of June 9, 2026.
ALT5 Sigma renamed AI Financial Corporation; Nasdaq ticker changes to AIFC
Name change effective April 28, 2026; ticker change at market open April 29, 2026.
ALT5 Sigma acquires Block Street Corp. and Dectec; issues stock and pre-funded warrants
Acquired Block Street for 12,670,257 common shares valued at $12M plus $15M and $16M pre-funded warrants with performance milestones.
ALT5 Sigma names Tony Isaac permanent CEO with $600k salary, 5M share grant
Tony Isaac's title changed from Acting CEO to CEO; Employment Agreement approved April 20, 2026.
ALT5 Sigma regains full Nasdaq compliance; all three listing deficiencies cured
Filed Q3 10-Q on Jan 12, 2026; Nasdaq confirmed compliance with Listing Rule 5250(c)(1) on Jan 13.
ALT5 Sigma shareholders elect all seven directors and ratify auditor at annual meeting
Elected directors: Zachary Witkoff, Tony Isaac, Zachary Folkman, Nael Hajjar, John Bitar, Dr. Adel Elmessiry, Tim Stanley.
ALT5 Sigma reports NAV $6.67/share, stock trades at $1.52 (77% discount); compliance restored
Estimated NAV of $843M ($6.67/share) vs. market cap ~$192M; shares trade at 77% discount.
ALT5 Sigma appoints Tim Stanley as independent director and audit committee member
Mr. Stanley appointed to Board and Audit Committee effective January 30, 2026.
ALT5 Sigma appoints Dr. Adel ElMessiry as independent director
Dr. Adel ElMessiry appointed to Board as independent director effective January 29, 2026.
ALT5 Sigma subsidiary secures $15M loan from World Liberty Financial, collateralized by WLFI tokens
$15M loan at 4.50% per annum, 24-month maturity; drawn fully on Jan 29, net proceeds ~$14.2M after prepaid interest and fees.
ALT5 Sigma appoints Steven M. Plumb as CFO with base salary of $339,400
Steven M. Plumb appointed CFO effective Nov 24, 2025; employment agreement finalized Jan 21, 2026.
ALT5 Sigma sets 2025 annual meeting for Feb 27, 2026; record date Jan 30
Annual Meeting scheduled for February 27, 2026, held virtually.
ALT5 Sigma dismisses newly-hired auditor Victor Mokuolu, engages L J Soldinger
Dismissed Victor Mokuolu, CPA PLLC on Dec 25, 2025; auditor had been engaged 17 days with no audit reports issued.
CEO Peter Tassiopoulos to depart ALT5 Sigma on Dec 15, 2025; Acting CEO Tony Isaac named
Mutual separation agreement with CEO Peter Tassiopoulos; effective Dec 15, 2025.
ALT5 Sigma settles litigation with Wellington Peel parties; pays $200K and issues 275K shares
Settlement resolves litigation filed Nov 5, 2025 with Wellington Peel, LLC, Jean-Francois Amyot, Hugues Benoit and Prime Delta Corp.
ALT5 Sigma appoints Victor Mokuolo CPA as new auditor for FY 2025
Effective Dec 8, 2025, Audit Committee approved Victor Mokuolo, CPA PLLC as independent auditor for fiscal year ending Dec 27, 2025.
Director David Danziger resigned Nov 25, 2025, causing audit committee to lack three independent members required by Nasdaq Rule 5605.
Auditor Hudgens resigns; going-concern uncertainty previously noted
Hudgens CPA resigned effective Nov 21, 2025 due to retiring partner; no disagreements with Company.
Alt5 Sigma appoints Tony Isaac acting CEO, Steven Plumb CFO; Hugh and Pitters exit
CFO/acting CEO Jonathan Hugh departed Nov 21, 2025 without cause; COO Ron Pitters given notice Nov 25, 2025.
ALT5 Sigma delays Q3 2025 10-Q filing citing incomplete review
Company will not file its September 27, 2025 quarterly report timely due to incomplete financial review.
ALT5 Sigma sues former consultant for data breach that may materially affect company
ALT5 Sigma filed lawsuit on Nov 4, 2025 in Delaware Chancery Court against Wellington Peel LLC, Jean-Francois Amyot, Hugues Benoit, and Prime Delta Corp.
Alt5 Sigma suspends CEO Peter Tassiopoulos; Jonathan Hugh named Acting CEO
Peter Tassiopoulos suspended as CEO effective Oct 16, 2025; removed of duties with pay.
ALT5 Sigma stockholders approve 10x increase in authorized common shares to 2 billion
Proposal 3 passed with ~56.8M votes for, ~13.1M against, 4,646 abstentions; no broker non-votes.
Alt5 Sigma shareholders approve 119M share issuance to World Liberty Financial
Proposal 1 passed: 36.99M for, 12.38M against — authorizing 119M shares issued to World Liberty Financial upon warrant exercise.
ALT5 Sigma clarifies token restrictions; gains ability to pledge, lend, or stake $WLFI tokens
Waiver of Token Prohibitions allows pledging, lending, and staking of $WLFI tokens, effective August 11, 2025.
$WLFI launched on Robinhood on Sept 25, accessible to 27.4 million retail users.
ALT5 Sigma cancels Alyea spin-off as previously planned; evaluating other strategic options
The spin-off of Alyea Therapeutics will not occur with the June 2, 2025 record date as previously disclosed.
ALT5 Sigma reports $WLFI holdings of 7.28B tokens valued at $1.3B
ALT5 holds 7,283,585,650 $WLFI tokens; market value ~$1.31B at $0.18 per token.
May 7, 2025 Rwanda court found ALT5 Sigma Canada and former principal Andre Beauchesne guilty of illicit enrichment; confiscated ~$3.5M; appeal filed June 6.
ALT5 Sigma closes $1.5B offering led by World Liberty Financial; Eric Trump joins board
Closed $1.5B offering: $750M cash from 100M shares at $7.50 plus $750M in $WLFI tokens; to hold ~7.5% of total $WLFI supply.
Incoming board observer Zak Folkman and incoming Chairman Zach Witkolf to appear on CNBC Squawk Box on August 12, 2025.
Registered direct offering of 100M shares at $7.50 for ~$750M gross; private placement receives $750M in $WLFI tokens for 1M shares + 99M pre-funded warrants.
ALT5 Sigma acquires Mswipe crypto-enabled payment card business
ALT5 acquired Mswipe, a multi-currency fiat/crypto payment card platform operating on Visa/Mastercard networks.
ALT5 Sigma loses longtime director Richard Butler; appoints David Danziger to board
Richard Butler passed away June 27, 2025; served as director since 2015, chaired Audit Committee.
ALT5 Sigma sets June 2 record date for Alyea separation; names prospective leadership
Record date of June 2, 2025 for Alyea separation; method (spin-off/split-off) to be announced later.
ALT5 Sigma sets June 2 record date for Alyea Therapeutics separation
Record date of June 2, 2025, for transaction to separate healthcare segment (Alyea Therapeutics).
ALT5 Sigma posts record Q1 fintech rev $5.51M, Adj EBITDA $1.15M; acquires Mswipe
Fintech revenue of $5.51M for Q1 2025, a record quarter.
ALT5 Sigma Q4 fintech revenue $5.4M; 1,000+ customers; appoints COO
Q4 fintech revenue $5.42M; full-year fintech revenue (from May 15) $12.53M; adjusted EBITDA ~$1.03M.
ALT5 Sigma to spin off healthcare assets into Alyea; LOI to acquire Soin Bioscience pain patch tech
All director nominees re-elected; CEO Peter Tassiopoulos elected to board for first time.
Non-binding term sheet signed Nov 19, 2024: Alyea Therapeutics to acquire 100% of Soin Bioscience from Dr. Amol Soin.
ALT5 Sigma reports record Q3 fintech revenue of $4.94M; net income $714K
Q3 fintech revenue $4.94M, gross profit $2.39M (~48% margin), net income $714K.
ALT5 Sigma appoints Peter Tassiopoulos as CEO; Tony Isaac moves to President/Chairman
Peter Tassiopoulos appointed CEO effective Sept 16, 2024; Tony Isaac steps down as CEO but remains President and Chairman.
Sold three units: one $1.784M debenture + 400,000-share warrant; two $404,454.39 debentures each + 90,909-share warrants.
JanOne changes name to ALT5 Sigma, ticker to ALTS, effective July 15, 2024
Name changed to ALT5 Sigma Corporation; Nasdaq ticker changes from JAN to ALTS as of July 15, 2024.
JanOne enters into $5M ATM equity offering with H.C. Wainwright
ATM agreement allows sale of up to $5M of common stock through agent H.C. Wainwright.
JanOne acquisition target Alt 5 Sigma reports 2023 net profit but auditor flags going concern
Alt 5 Sigma 2023 net profit $3.36M, revenue $11.97M (up 31% YoY); diluted EPS $0.13.
JanOne regains Nasdaq compliance on stockholders' equity as of June 4, 2024
Nasdaq letter confirms compliance with Listing Rule 5550(b)(1) based on $3.773M equity in March 31, 2024 10-Q.
JanOne settles SEC civil action; consents to $250K penalty and permanent injunction
Settlement with SEC resolves August 2021 complaint for alleged violation of Section 10(b) and Rule 10b-5.
JanOne acquires Alt 5 Sigma for ~$16M in equity; Alt 5 becomes wholly-owned subsidiary
Consideration: ~1.8M JanOne common shares (19.9% of outstanding) valued at $4.14/share, plus 34,207 Series B Preferred shares ($250 liquidation preference each).
Tony Isaac will step down as our Chief Executive Officer effective as of the Start Date. Tony will continue to serve as our President and will continue to serve as our Chairman on the Board of Directors (our “Board”).
appointed Peter Tassiopoulos to serve as our Chief Executive Officer, effective September 16, 2024
Effective October 5, 2021, JanOne Inc. (the “Company”) and its Board of Directors appointed Tony Isaac, the Company’s current Chief Executive Officer, as the Company’s Corporate Secretary.
Max materiality 1.00 · Median 0.60 · Most common event other_material